Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To assess the efficacy of continuous bevacizumab treatment beyond PD1 as measured by overall survival (OS).
Inclusion criteria
- ADVANCED NON-SQUAMOUS NON-SMALL CELL LUNG CANCER (NSCLC)